Before bone metastasis of breast cancer, tumor cells induce CD4+ T cells to express pro-osteoclastogenic cytokines IL-17F and RANKL (Receptor Activator of Nuclear Factor-κB Ligand) and promote the occurrence of bone loss [144]. This evidence concerns the gene CD4 and breast carcinoma.